Linden Capital Partners Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, Linden Capital Partners has acquired 3 companies. It has also invested in 1 other.

Linden Capital Partners’ most common sectors for investment arehealthcare services (27%) and medical products (27%) . The Firm’s most common investment types include secondary buyout (37%) and buyout (lbo, mbo, mbi) (27%). In total, Linden Capital Partners has invested in 18 US states and 2 different countries. Its largest (disclosed) acquisition occurred in 2013 when it acquired Young Innovations for $314M.

In the last 3 years, Linden Capital Partners has exited 3 companies. The Firm’s most common exit type is trade sale (43%). Linden Capital Partners’ largest (disclosed) exit occurred in 2004 when it sold Sovereign Specialty Chemicals for $575M.

Join Mergr to view Linden Capital Partners’ full profile and discover more large private equity firm investors just like it.

M&A Summary

  • M&A Total Activity67
    • M&A Buy Activity42
    • M&A Sell Activity25
  • Total Sectors Invested 13
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 35
  • M&A Advisors 10

Linden Capital Partners

150 N Riverside Plaza, Suite 5100,
Chicago, Illinois 60606
United States
(312) 506-5600
www.lindenllc.com
info@lindenllc.com

Linden LLC is a private equity firm that invests in businesses involved in the healthcare and life science sectors. However, the firm also executes any size private equity transaction between $10 million to $2 billion through the firm's alliance with Madison Dearborn Partners. Linden is not a venture capital investor. The firm specializes in investments in non-core businesses owned by large corporations, as well as traditional management buyouts of independent companies. Linden LLC was formed in 2004 and is based in Chicago, Illinois.


Investment Criteria

Sectors of Interest: Chemicals, Consumer Services, Distribution, Education, Healthcare Services, Life Science, Medical Products, Retail

Target Transaction Types: Buyout (LBO, MBO, MBI), Divestiture, Going Private, Growth Capital, Recapitalization, Secondary Buyout, Stake Purchase

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA 5 30
Investment Size - -
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (1.4/yr) # 35 5 2 - - - 42
vol $354M $354M
Sell (1.0/yr) # 21 2 3 - - - 26
vol $1.5B $1.5B
  68

Most Recent M&A

Company Date Value Type
Spear Education LLC 2022-12-19 - Secondary Buyout
Scottsdale, Arizona · www.speareducation.com
LifeStyles Healthcare Pte. Ltd. 2022-12-01 - Secondary Buyout
Singapore, Singapore · www.lifestylesglobal.com
Aspirion Health Resources 2022-06-21 - Stake Purchase
Columbus, Georgia · www.aspirion.com
Advarra, Inc. 2022-06-10 - Secondary Buyout
Columbia, Maryland · www.advarra.com
Smile Doctors LLC 2022-01-05 - Recapitalization
Georgetown, Texas · www.smiledoctors.com
Formulated Solutions LLC 2021-09-28 - Secondary Buyout
Largo, Florida · www.formulatedsolutions.com
GCX Corp. 2021-09-20 - Buyout (LBO, MBO, MBI)
Petaluma, California · www.gcx.com
BioIVT LLC 2021-08-24 - Secondary Buyout
Hicksville, New York · www.bioivt.com
RQM+ Corp. 2021-08-16 - Secondary Buyout
Monroeville, Pennsylvania · www.rqmplus.com
Flexan LLC 2021-07-26 - Add-on Acquisition
Lincolnshire, Illinois · www.flexan.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
BioIVT LLC 2021-08-24 SEKISUI XenoTech LLC 2022-09-12 5
Hicksville, New York · www.bioivt.com Kansas, Kansas · www.xenotech.com
Regenity Biosciences 2019-08-01 Sunstar's Degradable Solutions 2020-12-29 2
Oakland, New Jersey · www.regenity.com Schlieren, Switzerland · www.degradablesolutions.com
Healthcare Outcomes Performance Co. 2019-08-01 Stryker Corp. - Value-Based Care Business (BPCI) 2020-10-14 2
Phoenix, Arizona · www.hopco.com Kalamazoo, Michigan

M&A by Sector

Sector Current # Value All-time # Value
Medical Products 6 (27%) - 12 (26%) 314M (89%)
Healthcare Services 6 (27%) - 12 (26%) 40M (11%)
Life Science 4 (18%) - 9 (20%) -
Chemicals - - 2 (4%) -
Distribution - - 2 (4%) -
Packaging 2 (9%) - 2 (4%) -
Business Services 1 (5%) - 1 (2%) -
Consumer Products 1 (5%) - 1 (2%) -
Consumer Services - - 1 (2%) -
Education - - 1 (2%) -
Franchising 1 (5%) - 1 (2%) -
Information Technology 1 (5%) - 1 (2%) -
Test/Measurement Equipment - - 1 (2%) -
Total 22 - 46 $354M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 21 (95%) - 45 (98%) 354M (100%)
  Illinois 2 (9%) - 9 (20%) 314M (89%)
  California 2 (9%) - 5 (11%) -
  Pennsylvania 3 (14%) - 4 (9%) -
  Maryland 1 (5%) - 4 (9%) -
  Arizona 2 (9%) - 3 (7%) -
  Texas 2 (9%) - 3 (7%) -
  New Jersey 2 (9%) - 2 (4%) -
  Florida 2 (9%) - 2 (4%) -
  Tennessee 1 (5%) - 2 (4%) 40M (11%)
  Massachusetts - - 2 (4%) -
  Kansas - - 2 (4%) -
  Ohio 1 (5%) - 1 (2%) -
  New York 1 (5%) - 1 (2%) -
  Mississippi 1 (5%) - 1 (2%) -
  Georgia 1 (5%) - 1 (2%) -
  Connecticut - - 1 (2%) -
  North Carolina - - 1 (2%) -
  Michigan - - 1 (2%) -
Singapore 1 (5%) - 1 (2%) -
Domestic 21 (95%) - 45 (98%) 354M (100%)
Cross-border 1 (5%) - 1 (2%) -
Total 22 - 46 $354M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Secondary Buyout 13 (59%) - 17 (37%) -
Buyout (LBO, MBO, MBI) 4 (18%) - 12 (26%) 40M (11%)
Growth Capital 2 (9%) - 7 (15%) -
Going Private - - 2 (4%) 314M (89%)
Divestiture - - 2 (4%) -
Recapitalization 1 (5%) - 2 (4%) -
Stake Purchase 1 (5%) - 2 (4%) -
Acquisition Financing 1 (5%) - 1 (2%) -
Consolidation - - 1 (2%) -
Total 22 - 46 $354M

Exits by Deal Type

Type Total # Value
Secondary Sale 9 (35%) 10M (1%)
Trade Sale - Public Company 6 (23%) 894M (60%)
Trade Sale 6 (23%) 575M (39%)
Merger 1 (4%) -
Recapitalization 1 (4%) -
Sold to Management 1 (4%) -
SPAC 1 (4%) -
Unknown 1 (4%) -
Total 26 $1.5B

Top M&A Advisors

Financial Deals
Houlihan Lokey
 4
Jefferies
 4
William Blair
 2
Legal Deals
Kirkland & Ellis
 25
Paul Hastings LLP
 1
Bass, Berry & Sims PLC
 1

Deal Values

buy # Total
$100M to $1B 1 $314M
< $100M 1 $40M
TOTAL $354M
Largest Young Innovations, Inc.
$314M (2013-01-31)
sell # Total
$100M to $1B 4 $1.5B
< $100M 1 $10M
TOTAL $1.5B
Largest Sovereign Specialty Chemicals, Inc.
$575M (2004-12-27)

M&A Connections

Deals
Acquired from
Investor(s)
41%
19 (41%)
Strategic(s)
7%
3 (7%)
Exited to
Investor(s)
38%
10 (38%)
Strategic(s)
46%
12 (46%)

Investor Summary

Investor Type

Private Equity Firm

Size

Large

PE Assets

3.0B USD

Established

2004

Specialist/Generalist

Specialist

Leadership

Brian Miller

Co-Founder & Managing Partner

Anthony Davis

Co-Founder, Managing Partner & President

Alex Greeley

Partner

Kam Shah

Partner

Katie Kornel

Partner

 Subscribe to unlock this and 193,848
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 184K M&A Transactions
  • 189K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 72K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal